Amlodipine leaves your body slowly compared with most blood pressure medications, with an elimination half-life of roughly 40 to 60 hours. That means it takes about 10 to 12 days after your last dose for the drug to be essentially cleared from your bloodstream. The unusually long half-life is an inherent property of the molecule itself, not a feature of a special-release formulation, and it varies meaningfully with age, liver health, and what other medications you take.
What the Half-Life Actually Means for Clearance
A drug’s half-life is the time it takes for the amount in your blood to drop by half. Amlodipine’s half-life has been measured at around 34 to 36 hours after a single dose and closer to 45 hours after you’ve been taking it daily for a couple of weeks, because the drug gradually builds up in your tissues before reaching a steady state.1PubMed Central. The pharmacokinetics of amlodipine in healthy volunteers after single intravenous and oral doses and after 14 repeated oral doses given once daily Other reviews put the range at 40 to 60 hours.2PubMed. Pharmacokinetics and pharmacodynamics of amlodipine As a rough rule, a drug is considered cleared after about five half-lives. If your personal half-life sits at the lower end (around 35 hours), you’re looking at roughly 7 to 8 days. If it’s at the higher end (55 to 60 hours), clearance stretches to 12 to 13 days.
Amlodipine also has a very large volume of distribution, meaning it spreads widely into tissues rather than staying concentrated in the blood. In healthy volunteers given a single intravenous dose, the volume of distribution averaged about 21 liters per kilogram of body weight.1PubMed Central. The pharmacokinetics of amlodipine in healthy volunteers after single intravenous and oral doses and after 14 repeated oral doses given once daily That’s a huge reservoir. The drug seeps out of tissues slowly, which is a major reason the half-life is so long in the first place. It also means blood levels don’t tell the whole story: even after amlodipine is hard to detect in plasma, traces linger in tissue compartments for a while longer, though at levels too low to have a meaningful pharmacological effect.
If you’ve been taking amlodipine daily, the drug accumulates to about three times the single-dose level before reaching steady state, which typically happens after about seven consecutive doses.1PubMed Central. The pharmacokinetics of amlodipine in healthy volunteers after single intravenous and oral doses and after 14 repeated oral doses given once daily That accumulated drug has to wash out after your last pill, so the clock on “getting it out of your system” runs longer for someone who has been on it for weeks or months than for someone who only took a dose or two.
Why Blood Pressure Stays Lower Even Days After Stopping
One practical consequence of the long half-life is that missing a dose, or even stopping for a few days, doesn’t immediately send your blood pressure back up. In a double-blind trial, patients who stopped amlodipine for three days showed no significant increase in blood pressure compared with those who continued taking it.3PubMed. Prolonged antihypertensive effect of amlodipine: a prospective double-blind randomized study Another study comparing amlodipine with diltiazem (a calcium-channel blocker with a much shorter half-life) found that on the second day of a missed dose, most of amlodipine’s blood-pressure-lowering effect was still present, while diltiazem’s had largely worn off.4PubMed. Persistence of anti-hypertensive effect after ‘missed doses’ of calcium antagonist with long (amlodipine) vs short (diltiazem) elimination half-life
This is reassuring if you occasionally forget a pill, but it cuts both ways. If you’re trying to stop amlodipine because of a side effect like ankle swelling, the side effect won’t vanish overnight either. The drug’s slow washout means you may need a week or more before you notice the side effect fully resolving. A study of older hypertensive patients found that even during a planned drug holiday, blood pressure remained significantly lower than pre-treatment levels, confirming that meaningful drug activity persists well beyond the last dose.5Hypertension Research. The effects of missed doses of amlodipine and losartan on blood pressure in older hypertensive patients
A related advantage is that amlodipine doesn’t produce the rebound blood pressure spikes that some shorter-acting medications can trigger when stopped abruptly. The gradual decline in drug levels acts as a built-in taper, which provides better therapeutic coverage during any period of irregular dosing.6European Heart Journal. Therapeutic implications of drug ‘holidays’
How Amlodipine Is Broken Down
Your liver does most of the work. Amlodipine is metabolized primarily by a liver enzyme called CYP3A4, which converts it into inactive byproducts that your body can then excrete.7PubMed. Amlodipine metabolism in human liver microsomes and roles of CYP3A4/5 in the dihydropyridine dehydrogenation Only about 10% of the original drug ends up in urine unchanged; the rest leaves as metabolites. This liver-dependent clearance is the key variable that determines how quickly or slowly the drug exits your system, and it’s why liver function matters far more than kidney function for amlodipine clearance.
Age Slows Things Down
Older adults clear amlodipine more slowly than younger adults, and the difference is clinically meaningful. In one study of hypertensive patients, elderly participants had a mean elimination half-life of about 58 hours after an intravenous dose, compared with about 42 hours in younger patients, driven by a measurable decline in clearance.8PubMed. Effects of amlodipine, a long-acting dihydropyridine calcium antagonist in aging hypertension: pharmacodynamics in relation to disposition A separate study using oral doses found a similar pattern: a half-life of about 48 hours in elderly subjects versus 35 hours in younger ones.9American Heart Journal. The pharmacokinetic profile of amlodipine
That age-related slowing pushes the full clearance timeline from about 7 days for a younger person to roughly 12 days or longer for someone in their 70s or 80s. It’s one reason many older adults are started on a lower dose of amlodipine and why side effects can be more persistent in this group.
Liver Disease Makes a Big Difference, Kidney Disease Does Not
Because amlodipine depends so heavily on liver metabolism, severe liver impairment leads to higher blood levels and a longer half-life.10PubMed. Clinical pharmacokinetics of amlodipine People with significant liver disease will clear the drug noticeably more slowly, and prescribers often reduce the dose accordingly. If you have cirrhosis or another condition that meaningfully impairs liver function, amlodipine could linger well beyond the typical 10-to-12-day window.
Kidney disease, by contrast, has surprisingly little effect. A study of patients across a range of kidney function found that the half-life remained around 50 hours regardless of how impaired the kidneys were, and accumulation of the drug was no different from what you’d predict in healthy people.11PubMed. Pharmacokinetics of amlodipine in renal impairment Even patients on hemodialysis showed only minor differences in how they handled the drug, and amlodipine is essentially not removed by dialysis, meaning a dialysis session won’t speed up elimination.12PubMed. Pharmacokinetics of amlodipine in hypertensive patients undergoing haemodialysis The takeaway is straightforward: no dose adjustment is needed for kidney problems, but liver problems can meaningfully extend the drug’s stay in your body.
Drug Interactions That Change the Timeline
Since CYP3A4 is the main enzyme responsible for clearing amlodipine, anything that blocks or speeds up CYP3A4 will shift the elimination clock. In a population pharmacokinetic study, strong CYP3A4 inhibitors cut amlodipine clearance by about half and nearly doubled the total drug exposure in the body. On the flip side, efavirenz (which revs up CYP3A4 activity) increased clearance by roughly 40% and dropped drug exposure by nearly 60%.13PubMed Central. Population pharmacokinetic modelling to quantify the magnitude of drug-drug interactions between amlodipine and antiretroviral drugs
Common CYP3A4 inhibitors you might encounter include certain antifungal medications (like ketoconazole and itraconazole), some antibiotics (clarithromycin, erythromycin), and HIV protease inhibitors (ritonavir, for example). If you’re taking any of these alongside amlodipine, the drug will take longer to leave your system. Common CYP3A4 inducers include rifampin, certain anti-seizure medications, and the herbal supplement St. John’s wort, all of which could speed clearance and shorten amlodipine’s effect.
Genetics and How Fast You Personally Clear It
Not everyone’s CYP3A enzymes work at the same speed. Variations in the CYP3A5 gene can influence how quickly you metabolize amlodipine, though the effect is more modest than the age or drug-interaction effects described above. A study in healthy Korean volunteers found that people carrying a particular version of the CYP3A5 gene (the *1 allele, which produces a functional enzyme) had about 20% lower clearance and correspondingly higher peak blood levels of amlodipine than those who lacked it.14PubMed. Effect of CYP3A5*3 genotype on the pharmacokinetics and pharmacodynamics of amlodipine in healthy Korean subjects That translated into higher overall drug exposure but, interestingly, no significant difference in blood pressure response at the doses studied.
Where the genetic angle may matter more is with side effects. Research in Chinese patients with high blood pressure found that certain CYP3A5 gene variants were associated with an increased risk of the ankle swelling that amlodipine is known for.15PubMed Central. Association of CYP3A5 Gene Polymorphisms and Amlodipine-Induced Peripheral Edema in Chinese Han Patients with Essential Hypertension The people whose genetics resulted in slower metabolism likely had higher sustained drug levels, making edema more likely. This is an area where pharmacogenomics could eventually help guide dose selection, though routine genetic testing before prescribing amlodipine is not standard practice.
The Grapefruit Juice Question
Grapefruit juice is a well-known CYP3A4 inhibitor, and patients on many calcium-channel blockers are warned to avoid it. With amlodipine, the interaction turns out to be clinically trivial. One study found that grapefruit juice raised peak amlodipine blood levels by about 15%, a statistically detectable change that produced no measurable difference in blood pressure or heart rate.16PubMed. Effect of grapefruit juice on the pharmacokinetics of amlodipine in healthy volunteers A second study found essentially no change in any pharmacokinetic measure at all.17PubMed Central. Lack of effect of grapefruit juice on the pharmacokinetics and pharmacodynamics of amlodipine Compared with drugs like felodipine or nifedipine, where grapefruit can dramatically boost blood levels, amlodipine gets a pass. The reason likely relates to amlodipine’s high bioavailability (about 64%) and its reliance on liver CYP3A4 rather than the gut-wall CYP3A4 that grapefruit primarily affects.
How Amlodipine Compares with Other Calcium-Channel Blockers
Amlodipine’s long half-life is unusual among calcium-channel blockers. Nifedipine, for example, has an inherent half-life of only about 2 hours and relies on a sophisticated slow-release delivery system (GITS) to produce once-daily dosing.18PubMed. Quality of life and calcium channel blockade with nifedipine GITS versus amlodipine in hypertensive patients in Spain Felodipine, another member of the same drug class, also has a shorter elimination half-life than amlodipine.19PubMed. Effect of amlodipine versus felodipine extended release on 24-hour ambulatory blood pressure in hypertension The practical difference is that if you miss a dose of nifedipine GITS or felodipine, your blood pressure coverage can gap much more quickly. With amlodipine, that long tail means the drug is naturally forgiving of occasional lapses. On the other hand, it also means that if you experience a side effect, switching to or from amlodipine involves a longer transition period than switching between shorter-acting drugs.
What Happens in Overdose
In an intentional overdose, amlodipine’s already slow elimination gets even slower. A case report of a severe overdose documented peak plasma concentrations more than 20 times the upper therapeutic range, with levels still about 10 times normal four days after ingestion. The elimination half-life in that case was estimated at roughly 55 hours.20PubMed. Survival of severe amlodipine intoxication due to medical intensive care The liver’s metabolic machinery can become saturated when faced with a massive dose, meaning the enzyme responsible for breaking down the drug is maxed out and clearance slows further.21Chudoku kenkyu : Chudoku Kenkyukai jun kikanshi = The Japanese journal of toxicology. Delayed elimination half-life of amlodipine in a case of drug overdose Because dialysis doesn’t remove amlodipine, medical management of an overdose relies on intensive supportive care rather than any method of physically pulling the drug out of the blood.
Amlodipine During Pregnancy and Breastfeeding
Clearance questions take on extra urgency when another person’s exposure is at stake. Amlodipine does cross the placenta: one study measured it in cord blood at a level roughly 40% of the mother’s plasma concentration.22PubMed Central. Pharmacokinetics of amlodipine besylate at delivery and during lactation During breastfeeding, findings have been mixed. That same study found amlodipine concentrations in breast milk and infant plasma were undetectable. However, a separate study in women with pregnancy-related hypertension did find measurable drug levels in breast milk, with a milk-to-plasma ratio of about 0.85 and an estimated relative infant dose of around 4%.23PubMed. Amlodipine passage into breast milk in lactating women with pregnancy-induced hypertension and its estimation of infant risk for breastfeeding A relative infant dose below 10% is generally considered the threshold below which breastfeeding is usually deemed acceptable, so amlodipine falls within that range, but the decision is one to make with a prescriber given the individual circumstances.
S-Amlodipine Formulations
Amlodipine as most people take it is a 50/50 mixture of two mirror-image molecular forms, called S-amlodipine and R-amlodipine. The blood-pressure-lowering activity comes almost entirely from the S form. Some countries market a purified S-amlodipine product at half the dose of the racemic version. Whether this matters for clearance is worth mentioning: S-amlodipine tends to reach higher blood levels than R-amlodipine after a dose.24PubMed. Effect of cytochrome P450 3A5*3 genotype on the stereoselective pharmacokinetics of amlodipine in healthy subjects But the overall pharmacokinetic behavior of each form given individually is comparable to what you’d see from taking the standard racemic tablet.25PubMed. Pharmacokinetic behaviour of R-(+)- and S-(-)-amlodipine after single enantiomer administration In practical terms, the time to full elimination is similar regardless of which formulation you take. If you’ve been switched from standard amlodipine to an S-amlodipine product (or vice versa), the washout period is effectively the same.